These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27924370)

  • 1. High serum levels of complements C3 and C4 as novel markers for myeloma bone disease.
    Jiang F; Liu H; Liu Z; Song J; Li L; Ding K; Ren Y; Peng F; Shao Z; Fu R
    Ann Hematol; 2017 Feb; 96(2):331-333. PubMed ID: 27924370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of Detecting Serum Complement C3 and C4 in Patients with Multiple Myeloma].
    Li CJ; Xia HL; Wu YM; Ding G; Xu DD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):472-476. PubMed ID: 30998156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone disease in multiple myeloma: new markers, new treatments.
    Joshua D
    Intern Med J; 2001 Jul; 31(5):261-3. PubMed ID: 11512595
    [No Abstract]   [Full Text] [Related]  

  • 4. Complement components (C3, C4) as inflammatory markers in asthma.
    Abdel Fattah M; El Baz M; Sherif A; Adel A
    Indian J Pediatr; 2010 Jul; 77(7):771-3. PubMed ID: 20589464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of selective complement markers with schizophrenia.
    Mohd Asyraf AJ; Nour El Huda AR; Hanisah MN; Norsidah KZ; Norlelawati AT
    J Neuroimmunol; 2022 Feb; 363():577793. PubMed ID: 34990981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of serum complement (C3 and C4) levels in normal human pregnancy: effect of the development of pregnancy-associated hypertension.
    Gallery ED; Raftos J; Gyory AZ; Wells JV
    Aust N Z J Med; 1981 Jun; 11(3):243-5. PubMed ID: 6945834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel markers in osteo-oncology: the tartrate resistant acid phosphatase in myeloma bone disease].
    Strippoli S; Stucci S; Dammacco F; Silvestris F
    Recenti Prog Med; 2011 Feb; 102(2):88-95. PubMed ID: 21513124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma.
    Demacq C; Montenegro MF
    Clin Chem Lab Med; 2006; 44(2):232; author reply 233. PubMed ID: 16475914
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.
    Palikhe A; Sinisalo J; Seppänen M; Haario H; Meri S; Valtonen V; Nieminen MS; Lokki ML
    Am J Cardiol; 2007 Apr; 99(7):890-5. PubMed ID: 17398178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Converse changes in serum levels of immunoglobulins (IgG, A and M) and complement components (C3, 4) during pregnancy].
    Yasuhara M; Tamaki H; Iyama S; Yamaguchi Y; Amino N; Miyai K
    Rinsho Byori; 1991 Nov; 39(11):1195-8. PubMed ID: 1762197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of nizofenone on the symptomatic vasospasm after aneurysmal subarachnoid hemorrhage and its relationship to the levels of serum complements (CH50, C3 and C4)].
    Ogata N; Yonekawa Y; Kawano T; Tsukahara T
    Nihon Geka Hokan; 1991 Mar; 60(2):135-9. PubMed ID: 1819244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concentration of complement C3 and C4 in sera containing monoclonal IgA or IgG].
    Bartelik S
    Przegl Lek; 1990; 47(2):265-7. PubMed ID: 2356335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.
    Shingu M; Todoroki T; Sakai K; Nobunaga M
    J Rheumatol; 1981; 8(6):910-6. PubMed ID: 7328566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of complement components 3 and 4 in liver disease.
    Lodi TZ; Hassan TJ; Zuberi SJ
    J Pak Med Assoc; 1981 Feb; 31(2):33-5. PubMed ID: 6785483
    [No Abstract]   [Full Text] [Related]  

  • 15. Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, C3 proactivator (factor B) and C4 in gingival fluid.
    Schenkein HA; Genco RJ
    J Periodontol; 1977 Dec; 48(12):778-84. PubMed ID: 338883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
    Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM
    Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MRNA expression of complement C3 and C4 in rat nasal mucosa with allergic rhinitis].
    Lang JT; Sun AH; Fan JP; Tian SC; Jia R; Cao PY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Dec; 41(12):928-31. PubMed ID: 17345707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors.
    Nilsson B; Hamad OA; Ahlström H; Kullberg J; Johansson L; Lindhagen L; Haenni A; Ekdahl KN; Lind L
    Eur J Clin Invest; 2014 Jun; 44(6):587-96. PubMed ID: 24754458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there relationship between SARS-CoV-2 and the complement C3 and C4?
    Dheir H; Sipahi S; Yaylaci S; Köroğlu M; Erdem AF; Karabay O
    Turk J Med Sci; 2020 Jun; 50(4):687-688. PubMed ID: 32421281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.